No data to show
XCNQ
CXXI
Market cap18mUSD
Jun 16, Last price
0.21CAD
1D
2.50%
1Q
0.00%
IPO
-90.47%
Name
C21 Investments Inc
Chart & Performance
P/E
—
P/S
0.68
EPS
—
Div Yield, %
—
Shrs. gr., 5y
31.10%
Rev. gr., 5y
61.36%
Revenues
27m
-7.67%
Net income
-3m
L
CFO
907k
-84.62%
Earnings
Aug 14, 2025
Profile
C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. It offers packaged and wholesale flower, vaporizer pens, cured extracts, edibles, pre-rolls, tinctures, and topicals; and payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑01 | 2023‑01 | 2022‑01 | 2021‑01 | 2020‑01 | 2019‑01 | 2018‑01 | 2017‑01 | 2016‑01 | |
| Income | |||||||||
Revenues | 26,672 -7.67% | 28,888 -12.41% | |||||||
Cost of revenue | 25,284 | 23,568 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 1,388 | 5,320 | |||||||
NOPBT Margin | 5.21% | 18.42% | |||||||
Operating Taxes | 3,482 | 2,810 | |||||||
Tax Rate | 250.80% | 52.81% | |||||||
NOPAT | (2,094) | 2,510 | |||||||
Net income | (3,305) -339.25% | 1,382 -87.34% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (575) | ||||||||
BB yield | 0.90% | ||||||||
| Debt | |||||||||
Debt current | 1,531 | 3,582 | |||||||
Long-term debt | 18,760 | 17,508 | |||||||
Deferred revenue | (90) | ||||||||
Other long-term liabilities | 124 | 467 | |||||||
Net debt | 17,897 | 19,198 | |||||||
| Cash flow | |||||||||
Cash from operating activities | 907 | 5,900 | |||||||
CAPEX | (309) | (442) | |||||||
Cash from investing activities | (391) | (391) | |||||||
Cash from financing activities | (6,684) | (6,684) | |||||||
FCF | (129) | 309 | |||||||
| Balance | |||||||||
Cash | 2,394 | 1,892 | |||||||
Long term investments | |||||||||
Excess cash | 1,060 | 447 | |||||||
Stockholders' equity | 31,048 | 33,687 | |||||||
Invested Capital | 40,834 | 46,382 | |||||||
ROIC | 5.22% | ||||||||
ROCE | 3.31% | 11.34% | |||||||
| EV | |||||||||
Common stock shares outstanding | 120,048 | 122,881 | |||||||
Price | 0.53 55.88% | 0.34 -41.38% | |||||||
Market cap | 63,625 52.29% | 41,780 -40.54% | |||||||
EV | 81,522 | 60,978 | |||||||
EBITDA | 3,613 | 7,654 | |||||||
EV/EBITDA | 22.56 | 7.97 | |||||||
Interest | 35 | 457 | |||||||
Interest/NOPBT | 2.54% | 8.58% | |||||||